Page 239 - Influenza point of care testing: a Sheffield Teaching Hospital experience

Dr Cariad Evans, Dr Mohammad Raza and Dr Sabeen Khurshid Zaidi

References

  1. World Health Organization. Up to 650 000 people die of respiratory diseases linked to seasonal flu each year. Accessible at: www.who.int/news-room/detail/14-12-2017-up-to-650-000-people-die-of-respiratory-diseases-linked-to-seasonal-flu-each-year.
  2. Dugas AF, Valsamakis A, Atreya MR, Thind K, Alarcon Manchego P, Faisal A et al. Clinical diagnosis of influenza in the ED. Am J Emerg Med. 2015;33:770–775.
  3. Pitman RJ, Melegaro A, Gelb D, Siddiqui MR, Gay NJ, Edmunds WJ. Assessing the burden of influenza and other respiratory infections in England and Wales. J Infect. 2007;54(6):530–538.
  4. Davis S, Allen AJ, O'Leary R, Power M, Price DA, Simpson AJ et al. Diagnostic accuracy and cost analysis of the Alere in Influenza A&B near-patient test using throat swabs. J Hosp Infect. 2017;97(3):301–309.
  5. Brendish NJ, Malachira AK, Armstrong L, Houghton R, Aitken S, Nyimbili E et al. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial. Lancet Respir Med. 2017;5(5):401–411.